| Relation | Metric | Value | YoY |
|---|
Where did the money come from, and where was it spent?
Revenue and operating profit grew together, indicating healthy core operations.
Operating margin improved by 1.24 percentage points year over year.
- Revenue
- USD 9.76B YoY +13.73%
- Largest revenue segment share (Cardiovascular)
- 40.25% YoY +1.96pp
- Cost of revenue
- USD 3.42B Share 35.01% · YoY +13.83%
- Selling, general and administrative
- USD 3.20B Share 32.78% · YoY +13.97%
View calculation evidence
YoY periods: Q1 2027 compared with Q1 2026
Source metrics
- RevenueNet sales · RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenueCost of products sold, excluding amortization of intangible assets · CostOfGoodsAndServicesSold
- Selling, general and administrativeSelling, general, and administrative expense · SellingGeneralAndAdministrativeExpense
- Largest revenue segment share (Cardiovascular)Cardiovascular · segment_value / revenue * 100
- Operating marginReportable segment operating profit · operating_income / revenue * 100